Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ASTRAZENECA PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-23
ADCOCK INGRAM
Jun-14
ASTRAZENECA PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs3,620320-   
Low Rs2,438231-   
Sales per share (Unadj.) Rs401.295.1-  
Earnings per share (Unadj.) Rs39.7-24.0-  
Cash flow per share (Unadj.) Rs46.2-19.9-  
Dividends per share (Unadj.) Rs16.000-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs234.474.6-  
Shares outstanding (eoy) m25.00168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.52.9 260.9%   
Avg P/E ratio x76.3-11.5 -664.1%  
P/CF ratio (eoy) x65.5-13.9 -472.9%  
Price / Book Value ratio x12.93.7 350.4%  
Dividend payout %40.30-   
Avg Mkt Cap Rs m75,71846,446 163.0%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m2,5912,915 88.9%   
Avg. sales/employee Rs Th03,739.2-  
Avg. wages/employee Rs Th0679.0-  
Avg. net profit/employee Rs Th0-942.2-  
INCOME DATA
Net Sales Rs m10,03016,052 62.5%  
Other income Rs m261112 232.2%   
Total revenues Rs m10,29116,165 63.7%   
Gross profit Rs m1,249-2,782 -44.9%  
Depreciation Rs m163693 23.5%   
Interest Rs m6435 1.4%   
Profit before tax Rs m1,341-3,797 -35.3%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m348237 146.7%   
Profit after tax Rs m993-4,045 -24.5%  
Gross profit margin %12.5-17.3 -71.9%  
Effective tax rate %26.0-6.2 -415.4%   
Net profit margin %9.9-25.2 -39.3%  
BALANCE SHEET DATA
Current assets Rs m9,35911,757 79.6%   
Current liabilities Rs m4,8446,615 73.2%   
Net working cap to sales %45.032.0 140.5%  
Current ratio x1.91.8 108.7%  
Inventory Days Days49111 44.6%  
Debtors Days Days39124 31.6%  
Net fixed assets Rs m2,0616,853 30.1%   
Share capital Rs m5075 67.1%   
"Free" reserves Rs m5,8110-   
Net worth Rs m5,86112,599 46.5%   
Long term debt Rs m04,428 0.0%   
Total assets Rs m11,42123,801 48.0%  
Interest coverage x213.9-7.7 -2,765.8%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.90.7 130.2%   
Return on assets %8.7-15.2 -57.7%  
Return on equity %16.9-32.1 -52.8%  
Return on capital %23.0-19.8 -116.0%  
Exports to sales %00-   
Imports to sales %37.40-   
Net fx Rs m-3,1350-   
CASH FLOW
From Operations Rs m5831,370 42.5%  
From Investments Rs m181-421 -43.0%  
From Financial Activity Rs m-2454,018 -6.1%  
Net Cashflow Rs m5194,968 10.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.41 Rs / ZAR

Compare ASTRAZENECA PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ASTRAZENECA PHARMA With: EMMESSAR CHM  AVON ORGANIC  VILIN BIO MED  CHEMO PHARMA  INNOVA CAPTAB LTD.  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.